It detected more women with clinically relevant cancers and the authors say there’s a case for implementing it in screening programmes. The randomised control trial involved more than 100,000 Swedish women. Cancer diagnoses after AI-supported mammography were 12% lower, and the women were less likely to be diagnosed with more aggressive and advanced breast cancer in the years that followed. Estimates suggest 20-30% of breast cancers diagnosed after a negative screening and before the next scheduled one (interval cancers) could have been identified at the initial appointment. “It finds that AI-supported screening improves the early detection of clinically relevant breast cancers, which led to fewer aggressive or advanced cancers diagnosed in between screenings,” she said.